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Despite recent advances in the molecular genetics of type 2 diabetes, the majority of susceptibility genes in humans
remain to be identified. We therefore conducted a 10-cM genomewide search (401 microsatellite markers) for type
2 diabetes–related traits in 637 members of 143 French pedigrees ascertained through multiple diabetic siblings,
to map such genes in the white population. Nonparametric two-point and multipoint linkage analyzes—using the
MAPMAKER-SIBS (MLS) and MAXIMUM-BINOMIAL-LIKELIHOOD (MLB) programs for autosomal markers
and the ASPEX program for chromosome X markers—were performed with six diabetic phenotypes: diabetes and
diabetes or glucose intolerance (GI), as well as with each of the two phenotypes associated with normal body weight
(body-mass index!27 kg/m2) or early age at diagnosis (!45 years). In a second step, high-resolution genetic mapping
(∼2 cM) was performed in regions on chromosomes 1 and 3 loci showing the strongest linkage to diabetic traits.
We found evidence for linkage with diabetes or GI diagnosed at age !45 years in 92 affected sib pairs from 55
families at the D3S1580 locus on chromosome 3q27-qter using MAPMAKER-SIBS (MLS p 4.67, ),Pp .000004
supported by the MLB statistic ( , ). We also found suggestive linkage between theMLB-LODp 3.43 Pp .00003
lean diabetic status and markers APOA2–D1S484 (MLS p 3.04, ; , )Pp .00018 MLB-LODp 2.99 Pp .00010
on chromosome 1q21-q24. Several other chromosomal regions showed indication of linkage with diabetic traits,
including markers on chromosome 2p21-p16, 10q26, 20p, and 20q. These results (a) showed evidence for a novel
susceptibility locus for type 2 diabetes in French whites on chromosome 3q27-qter and (b) confirmed the previously
reported diabetes-susceptibility locus on chromosome 1q21-q24. Saturation on both chromosomes narrowed the
regions of interest down to an interval of !7 cM.
Introduction
Type 2 diabetes (MIM 125853) is a heterogeneous dis-
order of glucose metabolism characterized by both in-
sulin resistance and pancreatic b-cell dysfunction. The
chronic hyperglycemia is often associated with essential
hypertension, obesity, and dyslipidemia in a complex
metabolic syndrome leading to severe vascular compli-
cations, including blindness, end-stage renal failure, and
coronary-heart disease. The prevalence of type 2 dia-
betes in Westernized countries is 3%–10%, and epide-
miological studies predict it may reach a total of 30%
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in the next decade, which makes it a major health prob-
lem worldwide.
The familial clustering of type 2 diabetes, together
with the higher concordance rates in MZ twins com-
pared with DZ twins (Barnett et al. 1981; Hopper et
al. 1999) and the close correspondence in hybrid pop-
ulations, between genetic-admixture rates and disease
prevalence (Knowler et al. 1988), suggest a genetic pre-
disposition to type 2 diabetes, with a recurrence risk to
first-degree relatives of ∼3.5 (Rich 1990). In !10% of
the cases, type 2 diabetes appears to segregate in a Men-
delian fashion. However, in the majority of cases, the
pattern of inheritance of the disease suggests a complex
genetic interaction with environmental factors.
Considerable effort has been made worldwide during
the last decade to identify the underlying genetic deter-
minants. Studies of monogenic forms of type 2 diabetes
led to the identification of several diabetogenes with
major effects in rare families, including the insulin, in-
sulin-receptor, and glucokinase genes and the four tran-
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scription-factor genes encoding HNF1-a, HNF4-a,
HNF1-b (hepatocyte nuclear factor), and IPF1 (insulin
promoter factor 1), as well as mutations in the mito-
chondrial DNA (reviewed by Elbein et al. [1997]). How-
ever, these genes do not seem to play a major role in
the more common forms of type 2 diabetes. Studies of
candidate genes in pathways impaired in subjects with
type 2 diabetes led to the identification of genes that
may increase the risk for type 2 diabetes, including the
IRS1 (insulin receptor substrate 1), glucagon-receptor,
glycogen synthase, sulfonylurea-receptor, and IPF1
genes (Elbein et al. 1997). In any case, these genes con-
tribute, to a modest or marginal extent, to genetic sus-
ceptibility to type 2 diabetes.
Several groups, therefore, have undertaken genome-
wide scans to identify loci for type 2 diabetes and related
phenotypes. So far, genomewide significant linkages
(Lander and Kruglyak 1995) for such susceptibility loci
were identified on several distinct chromosomes in dif-
ferent populations. These include loci on chromosomes
2q37 (Hanis et al. 1996), 15q21 (Cox et al. 1999),
10q26 (Duggirala et al. 1999), and 3p (Ehm et al. 2000)
in Mexican Americans; 12q24 (Mahtani et al. 1996)
and 1q21-1q23 (Elbein et al. 1999) in whites; and 1q21-
1q23 and 11q23-q25 in Pima Indians (Hanson et al.
1998). Overall, these results underscore the genetic het-
erogeneity of type 2 diabetes in diverse ethnic groups
and the need of performing carefully designed whole-
genome scans in other populations, either to identify
new diabetes-susceptibility genes and/or to replicate
previous findings.
To search for a major susceptibility locus (loci) con-
tributing to type 2 diabetes in the French white popu-
lation, we have completed a genomewide search for di-
abetes-related traits in 143 families with affected sib
pairs. Here, we report evidence for a novel susceptibility
locus for diabetes on chromosome 3q27-qter and in-
dependent confirmation of a locus on chromosome
1q21-q24. Subsequent fine-mapping in those regions
has narrowed down the regions of interest to an interval
of !7 cM.
Subjects
Families have been recruited since 1990 by means of a
publicly advertised campaign for “200 families to over-
come diabetes,” and details of the recruitment have been
described elsewhere (Vionnet et al. 1997). Among the
402 type 2–diabetes families collected with at least two
affected sibs, 145 have been initially included in the
study, according to criteria the aim of which was to
reduce heterogeneity of the families and to maximize the
power of the study. A family was included if there were
at least two diabetic subjects in the sibship being treated
for diabetes (to load the families with a severe form of
type 2 diabetes) and at least three individuals (parents
or additional sibs) available for the study (to assist the
reconstruction of parental genotypes and to avoid non-
full sibs). Families presenting bilineal inheritance of type
2 diabetes or families with subjects diagnosed at age !25
years (i.e., potentially having the Maturity-Onset Dia-
betes of the Young [MODY] phenotype) or at age 165
years only (potential phenocopy caused by environmen-
tal factors rather than genetic ones) or families with mix-
ture of type 1 and type 2 diabetes (potential Latent Au-
toimmune Diabetes of Adults [LADA]) were discarded.
However, in one family, one individual was diagnosed
at age 23 years and had positive anti-GAD antibodies.
Nonwhite families or families with mutations in a
known diabetes-susceptibility gene were also excluded
from the study. Prior to genotyping of all the markers
for the genome scan, 18 markers for the X chromosome
(panel 28) were analyzed to check for DNA inconsis-
tencies and Mendelian inheritance. From a preliminary
selection of 145 families, 10 were discarded and were
replaced by 12 additional families checked in the same
manner. After the genome scan was completed, four fam-
ilies had to be discarded from the analyses because of
recurrent Mendelian incompatibilities. All analysis re-
sults presented in this report were thus obtained in 143
families, corresponding to 148 nuclear families.
Phenotypes were determined in the light of the clinical
report and the results of the latest measurements for
fasting and/or oral glucose-tolerance test according to
the recently established American Diabetes Association
criteria for type 2 diabetes (Expert Committee on the
Diagnosis and Classification of Diabetes Mellitus 1997):
“diabetic” (DM) when receiving oral hypoglycemic
agents or insulin 1 year after the diagnosis, or when
fasting glycemia was 7 mmol/l or glycemia 2 h after an
oral glucose load was 11.1 mmol/l; “glucose intolerant”
(GI) when fasting glycemia was 6.1–7.0 mmol/l or when
2-h glycemia was 7.8–11.1 mmol/l; “normoglycemic”
(NG) when fasting glycemia was !6.10 mmol/l and 2-
h glycemia was !7.8 mmol/l; “unknown” (UK) when
no data were available or type 1 diabetes was present.
Accordingly, the 637 individuals included in the study
comprised 432 DM, 72 GI, 129 NG, and 4 UK subjects
(tables 1 and 2). We designed six qualitative traits, tak-
ing into account the diabetic status, the age at diagnosis,
and the body-mass index (BMI) of each subject in an
attempt to stratify families into clinically more-homo-
geneous groups (table 3A). A maximum number of 677
affected sib pairs were analyzed with the affection status
“large,” and details of the family structure are given in
table 3B for all six subgroups. Both parents were avail-
able in 6 families, and one parent was available in 30
more families.
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Table 1
Clinical Characteristics of All Participants
Participant Status
Sex
Ratio
(M:F)
Age at Time of Study
(years)
 SD (range)
Age at Diagnosis
(years)
 SD (range)
Duration of Disease
(years)
 SD (range)
BMI
(kg/m2)
 SD (range)
Nondiabetic ( )np 129 40:89 61.8712.69 (28–91) … … 25.14.1 (14.98–36.71)
Diabetic ( )np 432 198:234 62.859.6 (31–93) 49.510.65 (23–83) 13.419.8 (0–63) 27.894.48 (15.11–45.91)
Glucose intolerant ( )np 72 36:36 61.159.41 (41–87) 59.069.56 (41–82) 2.084.49 (0–24) 27.374.70 (19.23–41.77)
Methods
Genotyping
Initial 10-cM genomewide screen.—Genomic DNA
was isolated from leukocytes using the Puregene DNA
Isolation Kit, according to the supplier’s protocol (Gen-
tra Systems). Genotyping was performed using a flu-
orescently labeled human linkage-mapping set (PE-
LMSV2) comprising 400 highly informative micro-
satellite markers, with an average intermarker spacing
of 9.7 cM. Multiplex PCR conditions were set up for
each of the 28 panels in such a manner as to amplify
the 400 markers in 87 PCRs. PCR (95C for 12 min,
followed by 30 cycles of 94C for 15 s, 55C for 15 s,
72C for 30 s, and 72C for 10 min) was performed on
GeneAmp PCR system 9700 (Perkin-Elmer): 10-ml re-
actions; 40 ng of genomic DNA, 2.5 mM MgCl2, 0.25
mM each dNTP (Pharmacia), a variable amount
(0.2–1.5 pmol) of 5′ and 3′ primers, and 0.4 U AmpliTaq
Gold DNA polymerase (Perkin Elmer) in 1# PCR Buffer
II (Perkin Elmer). (Multiplex PCR conditions are avail-
able from the authors on request.)
Pooled amplification products were electrophoresed
through 5% polyacrylamide gels (Long Ranger Singel
pack [Perkin Elmer]) for 1.5 h at 2,000 V on 24-cm
plates on an ABI 377 DNA sequencer. An automated
96-channel pipettor Multimek 96 (Beckman) was used
for all the pipetting steps. Semiautomated fragment siz-
ing was performed by use of GENESCAN 3.0 software
(ABI), followed by allele calling with GENOTYPER 2.1
software (ABI). Each genotype was reviewed indepen-
dently by two members of the research team to confirm
the accuracy of allele calling. Marker D14S68 was re-
placed by D14S67 because of reading difficulties. All
markers but D12S310, the amplification of which failed,
were included in the analysis. Two additional markers
(D5S429 and D8S279) were added to the 399, to fill in
gaps 120 cM. The overall data dropout rate for the
255,437 genotypes (401#637) analyzed was !4%. The
average heterozygosity for the 401 markers used in the
first-stage genome search was 0.79. Incompatibilities
were searched for with the PED-CHECK 1.1 program
(O’Connell and Weeks 1998) and inconsistencies
resolved.
Fine mapping” genotyping.—After the first-stage ge-
nome search, we observed that linkage was primarily
supported with markers on 3q27-qter and 1q21-q24
across most methods and phenotypes. We then saturated
these regions with 16 additional genetic markers in each
region, to confirm and further localize the linkage re-
sults. Each of the 32 markers was amplified individually
by PCR, and genotyping was performed similarly to the
genomewide scan. In addition, PCR and genotyping
were performed a second time for the markers used in
the genome scan and were localized in 3q27-qter and
1q21-q24 loci (seven and five markers, respectively). The
overall data dropout rate for the 28,028 genotypes—16
# 2 additional  12 “genome-scan” markers # 637
individuals—analyzed in this second step was of 0.5%,
thus ensuring maximal informativity for multipoint
analyses. The information content for markers used in
the multipoint analyzes exceeded 0.85 for both regions.
Data Statistical Analysis
Nonparametric two-point and multipoint analyzes
were performed with the programs MAPMAKER-SIBS
2.0 (MLS; Kruglyak et al. 1995), by using the “un-
weighted” option, and MLBGH 1.0 (Abel and Muller-
Myhsok 1998), for autosomal markers. The maximum-
likelihood binomial (MLB) method, which is based on
the binomial distribution of parental marker alleles
among affected offspring, overcomes the common prob-
lem of multiple sibs by considering the sibship as a
whole. Two-point and multipoint analyzes of the chro-
mosome X markers were performed using ASPEX
(1998 David A. Hinds and Neil Risch). Allele fre-
quencies for the parameter file were generated from the
data with DOWNFREQ 1.1 (Terwilliger et al. 1995).
Marker map positions for the genomewide scan and
the high-resolution map on chromosome 3q27-qter were
obtained from the sex-averaged maps compiled by Ge´-
ne´thon and are given in Haldane centimorgans (cM).
The high-resolution map order, from the Ge´ne´thon map,
of all markers tested at 3q27-qter was consistent with
the Marshfield map order and with the results of map-
ping in the Genebridge 3 Radiation Hybrid Panel (Re-
search Genetics) (data not shown). Of the 16 additional
markers of chromosome 1q21-q24, 5 belonged to the
Marshfield sex-averaged linkage map. For the high-res-
olution map on chromosome 1q21-q24, we used the
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Table 2
Medication History of Diabetic Participants
Medication History
% of Diabetic
Participants
Diet alone 10.7
Sulfonylureas (Sf) 24.9
Biguanides (Bg) 14.0
Insulin 12.6
Sf and/or Bg  insulin 5.3
Sf  Bg 30.9
Glucor or mediator 1.6
map positions from the Marshfield map, since mapping
in the Genebridge 3 Radiation Hybrid Panel was more
consistent with the Marshfield map order than with the
Ge´ne´thon map. Intermarker distances in our sample
were systematically checked with a program derived
from VITESSE (O’Connell and Weeks 1995).
When we restrict the sample to young-onset diabetes
status, the sample size is reduced to 92 sib pairs, and
we observe unequal sibship sizes. It is then legitimate to
investigate the reliability of the P values. We simulated
the transmission of the marker keeping the familial struc-
ture and affection status. When the founders had typed
parents, we used their actual genotype and simulated the
allele transmission. When they were unknown, their
genotypes probability was determined according to the
population allele frequency and their offspring geno-
types. A total of 70,000 replicates were simulated
through Monte Carlo method and were analyzed with
MLBGH.
Results
First-Stage Genome Scan
Table 4 summarizes results of the multipoint analyses
of the 401 framework markers from the initial genome
scan. We considered any region with a Znorm of 2.3 and
a LOD score of 1.17 ( ) as “potentially interest-Pp .01
ing,” and we applied the criteria of Lander and Kruglyak
to further define regions of significant ( ,Z p 4.11norm
, ) or suggestive ( ,LODp 3.6 Pp .00002 Z p 3.19norm
, ) linkage. Overall, 26 of theLODp 2.2 Pp .0007
2,298 tests using the MLB statistics for the autosomal
chromosomes (383 markers tested for the six pheno-
types) gave LOD scores1.17 ( ), correspondingP  .01
to 22 distinct markers that were distributed in 15 distinct
genomic intervals (table 4A). The MLS statistics also
gave LOD scores 1.17 ( ) for those genomicP  .01
intervals (table 4A), as well as for markers in nine ad-
ditional regions (table 4B). Of the 108 tests performed
using the MLS statistics (with ASPEX program) for the
X chromosome, 2 showed indication of linkage (table
4C). Most of the multipoint results were supported by
single-point analyzes (data not shown). There was a clus-
ter of linked markers on chromosomes 3, 1, and 2. The
positive chromosome 3 markers ( ) spanned 138Pp .01
cM on the terminal q arm and gave positive results for
two of six diabetes phenotypes with both statistics. Ge-
nomewide significance was observed at the D3S1580
locus when the MLS statistic was used ( ,MLSp 3.91
for the “large young-onset” phenotype),Pp .00002
consistent with suggestive linkage using the MLB sta-
tistic ( , ). Linkage was still sug-LODp 2.97 Pp .00011
gestive with both statistical methods when applying a
conservative correction factor for the number of traits
studied by multiplying the P value by 6 (number of phe-
notypes). Linkage was also suggested in this chromo-
somal region with the “strict-young-onset” phenotype,
with both MLS and MLB statistics: at D3S1580;
, , ,MLSp 2.89 Pp .00026 MLB-LODp 2.24 Pp
(table 4A). When we restricted the sample to.00067
young-onset diabetes status, the sample size was reduced
to 92 sib pairs, and we observed unequal sibship sizes.
However, simulation studies for the chromosome 3 re-
sults showed that the empirical P values were very close
to the value expected under asymptotic conditions.
Therefore, we can rely on the P values given by the MLB
method.
The positive chromosome 1 markers spanned 120 cM
on the q arm and also gave positive results for two di-
abetes phenotypes. Suggestive linkage was observed with
the “strict-lean” phenotype with both the MLS and MLB
statistics, and results remained potentially interesting af-
ter Bonferroni correction. Positive results for chromo-
some 2 markers were primarily for the “strict” pheno-
type, with suggestion of linkage only with the MLB
analyses, and spanned an interval of 26 cM on the p
arm.
Second-Stage Mapping of Chromosomes 3q and 1q
From the first-stage scan, the strongest and most con-
sistent evidences for linkage were found for markers
from chromosomes 3q27-qter and 1q21-q24, across dif-
ferent analytical methods and different phenotypes. We
thus added 16 more markers in the 3q27-qter and 1q21-
q24 regions, for totals of 23 and 21 markers with av-
erage map densities of 2.6 and 1.9 cM, respectively. Fig-
ures 1A and 1B show results from the multipoint
analyzes for both MLS and MLB statistics of the satu-
ration of 3q with the “large young-onset” phenotype
and 1q with the “strict-lean” phenotype. These analyzes
further supported and strengthened the findings from
the initial 10-cM scan. Evidence of linkage was con-
firmed in the 3q27-qter region with both the “large
young-onset” and “strict young-onset” phenotypes
(D3S1580 ; and 3.56 ( andMLSp 4.67 Pp .000004
.000054, respectively) and 2.65MLB-LODp 3.43
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Table 3
Description of Affection Status and Structure of the 148 Nuclear Families
3A. DESCRIPTION OF AFFECTION STATUS FOR THE SIX PHENOTYPIC GROUPSa
Affection Status Large Strict Large-Lean Strict-Lean Large Young-Onset Strict Young-Onset
Affected NIDDMGI NIDDM (NIDDMGI)
with BMI
!27
NIDDM with
BMI !27
(NIDDMGI)
with age at
onset !46
NIDDM with age
at onset !46
Unknown NA NAGI NA(NIDDM
GI) with
BMI 127
NAGI
(NIDDM with
BMI 127)
NA(NIDDM
GI) with age at
onset 146
NAGI
(NIDDM
with age at
onset 146)
Nonaffected NG NG NG NG NG NG
3B. NO. OF FAMILIES WITH N AFFECTED IN EACH PHENOTYPIC GROUPb
n Large Strict Large-Lean Strict-Lean Large Young-Onset Strict Young-Onset
2 43 66 37 40 41 45
3 54 54 19 11 11 6
4 30 18 5 5 3 3
5 12 6 1
6 4 1 3 1
7 4 2
8 1
Total families 148 147 65 57 55 54
Total sib-pairs 677 453 179 113 92 81
a Affection status was determined taking into account patients’ diabetic status (overt diabetes [NIDDM], GI, NG, or data not
available [NA]), BMI (kg/m2), and age at diagnosis of diabetes. Three affection statuses were used for the statistical analyses:
affected, nonaffected, and unknown (coded 2, 1, and 0, respectively).
b Total number of sib pairs was calculated with the following formulae: (number of families with n affected, n p [2–8])
.X[nX(n 1)]/2
( and .00024, respectively). Moreover, thePp .00003
high-resolution mapping identified an indication of link-
age, which was not observed at the 10-cM initial genome
scan mapping phase, with an additional phenotype that
is the “strict” phenotype (i.e., type 2 diabetes) regardless
of the age at diagnosis (453 sib pairs, MLB-LODp
, ).1.28 Pp .007
On the other hand, although they did not reach the
Lander-Kruglyak statistical thresholds for significance,
results in the 1q21-q24 region were highly suggestive
with the “strict-lean” phenotype (APOA2–D1S484;
, ; ,MLB-LODp 2.99 Pp .00010 MLSp 3.04 Pp
). This saturation step with dense genetic map.00018
allowed us to restrict the 1-LOD-unit CI (Ott 1991) from
11 to 6.2 cM and from 19 to 6.5 cM for the loci on
chromosomes 3 and 1, respectively.
Discussion
The present genome scan in French whites provides (1)
strong evidence for a susceptibility locus for diabetes and
impaired glucose tolerance with early onset (at age !46
years) on chromosome 3q27-qter and (2) suggestive ev-
idence that there is a diabetes-susceptibility gene in
French whites in a previously reported region on chro-
mosome 1q21-q24. In our genomewide-scan design for
type 2 diabetes–susceptibility genes, emphasis has been
focused on power to maximize the chances for success.
We used a large number of sib pairs (1200 for the “large”
and “strict” phenotypes), and a 10-cM marker grid in
a one-stage study yielding a power of 198% for a risk
ratio (ls) of 3 and of 170% for a risk ratio (ls) of 2
(Holmans and Craddock 1997). Because genotyping er-
rors lead to false-positive or false-negative results, au-
tomation and stringent quality-control criteria have been
applied. Families were selected from among our large
collection to be as homogeneous as possible, to avoid
background noise caused by bilineal inheritance of the
trait (DeStefano et al. 1998), other genetic forms of type
2 and/or type 1 diabetes (such as MODY or LADA),
and nongenetic forms caused by environmental factors.
Only families in which accurate inference of relation-
ships among sib pairs was possible were included, to
avoid reduced power to detect linkage caused by mis-
classification of half-sib pairs or unrelated individuals as
full sibs (Boehnke and Cox 1997). Two powerful sib
pair–based methods were used for analyses: the MLS
method, which was previously shown to be most sen-
sitive (Davis and Weeks 1997), and the MLB method,
which takes into account sibships with several affecteds
in a natural way and was shown to perform well in terms
of type 1 error and power (Abel and Muller-Myhsok
1998; Abel et al. 1998).
Our best linkage result was found between markers
on chromosome 3q27-qter and diabetes and impaired
glucose tolerance diagnosed at age !45 years. Criteria
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Table 4
Multipoint Results of the 10-cM Genome-Scan Initial Stage
4A. RESULTS OF MLB AND MLS MULTIPOINT ANALYSES FOR SIX DIABETES-RELATED PHENOTYPES
Intervala Positive Markersb
Positionc
(cM) Phenotype MLB-LOD (P) MLS (P)
1p21 D1S206 141.12 Strict-lean 1.27 (.00777) 1.48 (.00782)
1q21-q24 D1S484, D1S498 178 Strict-lean 2.47 (.00037) 2.50 (.00066)
D1S484 178 Strict 1.23 (.00877) 1.12 (.01911)
1q43 D1S2785 276.23 Large young-onset 1.39 (.00575) 1.64 (.00533)
2p25 D2S319 6.17 Strict young-onset 1.61 (.00324) 2.02 (.00212)
2p21-p16 D2S2259, D2S391 75.31 Strict 2.28 (.0006) 2.27 (.00116)
2q24-q23 D2S2330 179.22 Large-lean 1.25 (.00826) 1.22 (.01507)
3q27-qter D3S1580, D3S1262, D3S1601 217.97 Large young-onset 2.97 (.00011) 3.91 (.00002)
D3S1580, D3S1601 217.97 Strict young-onset 2.24 (.00067) 2.89 (.00026)
4p16 D4S2935, D4S412 12.5 Large 1.34 (.00643) 1.35 (.01087)
4q31 D4S1539 185.99 Large-lean 1.87 (.00166) 2.09 (.00175)
5q31-q33 D5S410, D5S436 159.43 Large 1.52 (.00412) 1.67 (.00492)
7q11 D7S669 92.74 Large-lean 1.32 (.00682) 1.68 (.00479)
9q34 D9S158 160.01 Strict-lean 1.30 (.00724) 1.22 (.01494)
10q26 D10S1655 174.65 Strict 1.59 (.00342) 1.24 (.01427)
D10S212 185.23 Large 1.22 (.00899) 1.69 (.00472)
D10S212 185.23 Large-lean 1.44 (.00504) 1.45 (.00841)
11p15 D11S1338 15.24 Strict young-onset 1.34 (.00648) 1.25 (.01371)
19p13 D19S221 36.92 Large young-onset 1.20 (.00948) 1.26 (.01358)
4B. ADDITIONAL LOCI WITH MLS SCORE 11.17
Intervala Positive Markersb
Positionc
(cM) Phenotype MLB-LOD (P) MLS (P)
2p25 D2S168 29.3 Strict .82 (.02621) 1.90 (.00278)
2p23 D2S305 41.64 Large 1.16 (.0103) 1.98 (.0023)
D2S305 41.64 Large young-onset .62 (.04537) 1.60 (.00581)
D2S305 41.64 Strict young-onset .80 (.02707) 1.70 (.00459)
8q22 D8S270 104.72 Large .97 (.01723) 1.44 (.00865)
12p11 D12S345 55.56 Large young-onset .84 (.02447) 1.41 (.00925)
15q15 D15S1007 26.78 Strict young-onset .74 (.03211) 1.50 (.00753)
16p11 D16S3068 14.6 Strict young-onset 1.09 (.01253) 1.39 (.00971)
18q12 D18S478 54.71 Large young-onset 1.09 (.0126) 1.75 (.00401)
20p13-p12 D20S186 33.93 Large young-onset 1.14 (.01093) 1.86 (.00312)
D20S186, D20S115 33.93 Strict young-onset 1.08 (.01304) 1.68 (.00475)
20q13 D20S178 66.95 Large .05 (.06295) 1.72 (.00432)
4C. RESULTS OF ASPEX MULTIPOINT ANALYSES FOR SIX PHENOTYPES
Intervala Positive Markersb
Positionc
(cM) Phenotype MLB-LOD (P) MLS (P)
Xp11-p21 DXS991 89.34 Large 1.67 (.00491)
DXS991 89.34 Strict 1.56 (.00643)
a Chromosomes locations were determined from the map available in the Genome Database and the CEDAR
database.
b When several markers per line are shown, the first one is the nearest to the top of the peak.
c Map positions of the nearest marker to the top of the peak, obtained from sex-averaged maps compiled by
Ge´ne´thon.
for assessment of statistical significance in genetic-link-
age studies of complex traits have been controversial.
Specific critical values have been proposed; some in-
vestigators have suggested that a relatively stringent
threshold of is needed to obtain a genomewideZ 1 3.6
(Lander and Kruglyak 1995), whereas othersP ! .05
have maintained that the less stringent traditional cri-
terion of is unlikely to be a false positive (Hol-Z 1 3.0
mans et al. 1997; Morton 1998; Rao 1998). In addition,
when several correlated traits have been analyzed, it is
unclear how to adjust for multiple comparisons. The
present analysis provides strong evidence for linkage on
chromosome 3 with diabetes and impaired glucose tol-
erance diagnosed at age !45 years ( ) and forZp 4.67
diabetes diagnosed at age !45 years ( ). BothZp 3.56
two-point and multipoint MLS and MLB statistics gave
consistent results that were still significant after Bon-
ferroni correction for the number of phenotypes ana-
Figure 1 Results of the MLB and MLS multipoint analyses for the high-resolution genetic mapping at chromosome 3q27-qter with the
“large young-onset” phenotype (A) and at chromosome 1q21-q24 with the “strict-lean” phenotype (B). The thresholds for putative (LOD 1.17;
), suggestive (LOD 2.2; ), and significant linkage (LOD 3.6; ) are indicated by horizontal lines. Marker namesPp .01 Pp .0007 Pp .00002
followed by “.b” were also used in the first stage 10-cM genomewide screen and were fully retyped during the high-resolution mapping step
(see Methods section). The horizontal axis corresponds to the partial genetic map of chromosomes 3q27-qter and 1q21-q24 intervals studied
in the saturation step with high-density genetic maps. The vertical axis indicates the log(P) obtained with multipoint analyses at each point
in the studied interval.
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lyzed. In addition, the width of the peak on chromo-
some 3q27-qter, given by all positions providing a P
value of .01 in the multipoint analysis, was broad (120
cM), which is an argument in favor of this peak being
a true positive rather than a false positive (Terwilliger
et al. 1997). We found linkage on chromosome 3
through stratification of families in clinically more-ho-
mogeneous subgroups, which is known to help in iden-
tification of susceptibility loci for a complex disease
(Rao 1998). The result on chromosome 3q has been
observed in a subgroup of 55 non-MODY families
(37% of total families) with glucose intolerance or di-
abetes diagnosed between age 25 and 45 years, although
both parents were not affected. Therefore, this group
probably represents the most genetic form of non-
MODY type 2 diabetes. Results of simulation studies
showed that the nominal P values obtained in this re-
duced sample were reliable. On the basis of a single
sample, it is difficult to unambiguously distinguish true
from false linkage results. However, linkage of diabetes
to the chromosome 3q27-qter region is supported by
(1) the consistency of results across phenotypes and an-
alytical methods, (2) the extremely low P values, and
(3) the results of our simulations. Additional support
comes from replication of results either in the same pop-
ulation or in other populations. We could not perform
a replication study in our population, because the huge
size of the replication sample recommended by simu-
lation studies (Risch and Merikangas 1996) was incom-
patible with the small number of similarly ascertained
families remaining in our French collection. Our region
of positive linkage on chromosome 3q27-qter spanned
120 cM in the first-stage genome scan and was refined
to !7 cM after the fine-mapping step was conducted.
This region includes several reports of positive linkage
with metabolic traits; we agree with Neel and colleagues
(1998) that “type 2 diabetes, essential hypertension, and
obesity [are] syndromes of impaired genetic homeosta-
sis.” Hegele et al. (1999) found an indication of linkage
between D3S2418 and type 2 diabetes in a 20-cM ge-
nomewide scan in a Canadian Oji-Cree population
( ). They did not find evidence of linkage dise-Pp .01
quilibrium between D3S2418 and diabetes; neither did
we with D3S1580 in the 55 linked families using the
Monte Carlo–based x2 implemented in CLUMP (Sham
and Curtis 1995; data not shown). QTLs for impaired
acute insulin response, insulin resistance in nondiabetics
(Pratley et al. 1998) and in diabetics (Hanson et al.
1998), and waist:hip ratio (a measure for obesity) (Nor-
man et al. 1998) were also suggested in this chromo-
somal region, in the sole Pima Indian population. In-
terestingly, a QTL for small low-density lipoprotein–
particle phenotype, known to be a risk factor for car-
diovascular disease, has been recently mapped in the
same region on chromosome 3q27-qter (Rainwater et
al. 1999). Several studies have reported a polymorphism
in the apolipoprotein D (APOD) locus, in the region of
the maximal peak of our linkage at this chromosomal
region, to be associated with diabetes and obesity (Hit-
man et al. 1992; Vijayaraghavan et al. 1994). Although
none of those previously reported linkages on chro-
mosome 3 reached statistical significance, as did the
linkages in our study, they do strengthen our results,
and it is tempting to speculate that the same locus is
responsible for these results.
Saturation of the chromosome 3q27-qter region in
our families reduced the 1-LOD-unit confidence interval
(CI) to 6.2 cM around D3S1580, which, according to
the Unified Database for Human Genome Mapping,
spans ∼4.5 mb, an interval of suitable size to initiate
positional cloning and disequilibrium mapping efforts.
This chromosomal region contains several potentially
interesting genes, including the genes coding for so-
matostatin, apolipoprotein D, and inhibitor 2 of the
synthase-activating enzyme, type 1 protein phosphatase,
I-2 (PPP1R2), and the bifunctional enzyme (with enoyl-
CoA-hydratase and 3-hydroxyacyl-CoA dehydrogenase
activity) (MIM 182450, MIM 107740, MIM 601792,
and MIM 261515, respectively).
We also found evidence of linkage between markers
on chromosome 1q21-q24 and diabetes in lean patients
(with BMI !27). Although not reaching the stringent
statistical thresholds for significance, results on chro-
mosome 1q were highly suggestive ( ), and,Pp .00010
again, the broad width of the peak in the initial genome
scan (120 cM) also suggested true-positive results. Link-
age on chromosome 1q was also found through strat-
ification of families, in a homogeneous subgroup of 57
families (38% of families) in which diabetes is enriched
in lean patients. Since obesity is frequently associated
with diabetes and is genetically determined as well, it
could be a confounding variable in genetic studies of
diabetes. Therefore, genetic studies of lean diabetic pa-
tients are more likely to identify true diabetes-suscep-
tibility loci, rather than obesity-susceptibility loci. Our
results on chromosome 1q confirm (and replicate) pre-
vious reports of evidence for linkage between diabetes
and markers in the same region in at least two different
populations. Elbein et al. (1999) reported evidence of
linkage between diabetes and markers CRP/APOA2 in
19 multigenerational families of northern European an-
cestry from Utah using a recessive model for parametric
analyzes. In a study of the Pima Indians, among whom
diabetes and obesity are highly prevalent, Hanson et al.
(1998) found evidence of a diabetes locus on chromo-
some 1q, a region that was not linked to obesity in their
study. They observed a very strong evidence for linkage
with diabetes ( ) at D1S2127, in the 55 sib pairsZp 4.1
who had onset of diabetes at age !25 years, supported
by comparisons of sib pairs concordant for diabetes
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versus discordant sib pairs at D1S1677. The finding of
linkage in three different populations strengthens the
evidence for a diabetes-susceptibility locus in this
region.
Saturation of the chromosome 1q21-q24 region in
our families reduced the 1-LOD-unit CI to 6.5 cM
around APOA2/CRP, which, according to the Unified
Database for Human Genome Mapping, corresponds
to ∼6 mb. Indeed, positional cloning and disequilib-
rium-mapping efforts have already been initiated in di-
abetic Pima Indians to identify the chromosome 1q lo-
cus, and several of the potential candidate genes have
been screened (Baier et al. 1998; Wolford et al. 1999a).
These identified a linkage disequilibrium between dia-
betes and single-nucleotide polymorphisms near the
KCNJ9 gene coding for the G-protein-coupled inward
rectifier K() channel homolog GIRK3, suggesting that
the diabetes-susceptibility gene on chromosome 1q21-
q24 is closely linked to the KCNJ9 locus (Wolford et
al. 1999b). Linkage disequilibrium between diabetes
and chromosome 1 markers in the same region was also
found in the Old Order Amish (St. Jean 1999a, 1999b).
The possible role for those genes in the French families
that contributed to our linkage results is under
investigation.
We identified 22 other regions showing at least nom-
inal indication of linkage ( ). When looking veryP ! .01
closely at the published data, we found similar results
in other studies in most of our regions. Of particular
interest is our linkage result on chromosome 10q26 that
largely overlaps the region of linkage with diabetes and
age at onset of diabetes identified in Mexican Americans
(Duggirala et al. 1999). We were therefore able to rep-
licate their findings independently in our population.
Our suggestive linkage results on chromosome 2p21-
p16 with the diabetic phenotype are supported as well
by several reports for metabolic traits in that region,
mostly obesity-related phenotypes, including QTLs for
leptin levels, fat mass, or BMI in different populations
(Comuzzie et al. 1997; Hager et al. 1998; Rotimi et al.
1999). It is therefore possible that a genetic defect lo-
calized on chromosome 2p determines the occurrence
of both obesity and type 2 diabetes. It has already been
reported that some loci, such as the one on chromosome
11q23-q25, harbor diabetes and obesity genes (Hanson
et al. 1998).
As far as chromosome 20 is concerned, we were the
first to report positive linkage on chromosome 20q in
another selection of French diabetic families (Hani et
al. 1996; Zouali et al. 1997). Afterward, several studies
confirmed our findings (Bowden et al. 1997; Ji et al.
1997; Ghosh et al. 1999), including results of a meta-
analysis of all data available worldwide for this chro-
mosome (Boehnke et al. 1998). Obesity-related traits
have also been mapped on this chromosome (Lembertas
et al. 1997; Norman et al. 1998; Lee et al. 1999). From
our studies and others, it seems possible that there are
two diabetes- and/or obesity-susceptibility genes on
chromosomes 20p and 20q. Further fine mapping and
sequencing of selected candidates (HNF3-b, MC3R,
CEBP-b, and Nkx2.2) are under way to elucidate the
role of chromosome 20 genes in the French diabetics.
Because emphasis has been placed on power in our
genomewide-scan design for type 2 diabetes–sus-
ceptibility genes, in this study, we were able to exclude
linkage at the diabetes loci on chromosomes 2q37,
15q21, and 12q24—identified in Mexican-American
and Finnish subjects, respectively—as well as at the di-
abetes-and-obesity locus on chromosome 11q23-q25
that was identified in Pima Indians or the diabetes locus
recently mapped on chromosome 3p in Mexican Amer-
icans. It is therefore very likely that genes that play an
important role in isolated or recently admixed popu-
lations have a marginal role, if any, in a representative
admixed population such as these French whites.
In conclusion, we report the first evidence for a novel
diabetes-susceptibility locus gene on chromosome 3q27-
qter. Several results of positive, although not significant,
linkage at this locus that were previously reported in
the literature support our findings. In addition, we in-
dependently confirm linkage with diabetes in the 1q21-
q24 interval (Hanson et al. 1998; Elbein et al. 1999).
Other loci on chromosomes 2p21-p16, 10q26, and 20
are potentially interesting but await further studies to
be confirmed.
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